Sector
PharmaceuticalsOpen
₹68Prev. Close
₹66.95Turnover(Lac.)
₹29.04Day's High
₹70.29Day's Low
₹65.2152 Week's High
₹74.852 Week's Low
₹31.35Book Value
₹47Face Value
₹10Mkt Cap (₹ Cr.)
199.3P/E
47.15EPS
1.42Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 32.99 | 30.02 | 27.7 | 25.7 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 99.79 | 87.39 | 85.94 | 73.16 |
Net Worth | 132.78 | 117.41 | 113.64 | 98.86 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 348.41 | 300.08 | 349.34 | 395.96 |
yoy growth (%) | 16.1 | -14.1 | -11.77 | 60.94 |
Raw materials | -337.79 | -290.18 | -337.36 | -382.98 |
As % of sales | 96.95 | 96.69 | 96.56 | 96.72 |
Employee costs | -0.39 | -0.39 | -0.38 | -0.33 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 8.3 | 7.24 | 8.19 | 7.97 |
Depreciation | -0.92 | -0.89 | -0.71 | -0.64 |
Tax paid | -1.78 | -1.44 | -2.01 | -2.5 |
Working capital | 6.66 | 26.65 | 23.78 | 5.56 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.1 | -14.1 | -11.77 | 60.94 |
Op profit growth | 43.51 | -57.69 | -20.51 | 848.64 |
EBIT growth | 18.89 | -10.71 | -17.84 | 248.55 |
Net profit growth | 12.44 | -6.21 | 12.85 | 324.54 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,629.7 | 78.47 | 3,90,863.66 | 753.53 | 0.98 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,361.5 | 76.45 | 1,68,811.47 | 667 | 0.47 | 2,536 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,678.2 | 62.55 | 1,24,346.04 | 551 | 0.16 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,502.8 | 23.47 | 1,21,259.61 | 1,303.13 | 1.07 | 4,501.66 | 397.39 |
Mankind Pharma Ltd MANKIND | 2,566.3 | 58.43 | 1,05,753.49 | 412.76 | 0 | 2,541.36 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Mihir R Ghatalia
Independent Director
Chetan K Mehta
Independent Director
Lalit Tulsiani
Executive Director
Nimit R Ghatalia
Independent Director
Anil Mandal
Non Executive Director
Bina Ghatalia
Company Sec. & Compli. Officer
KAILASH CHAND JETHLIA
E-34 MIDC Tarapur,
Boisar,
Maharashtra - 401506
Tel: 91-22-23455543
Website: http://www.aareydrugs.com
Email: investorgrievance@aareydrugs.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally pro...
Read More
Reports by Aarey Drugs & Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.